Previous Article | Next Article 
Infection and Immunity, June 2000, p. 3286-3289, Vol. 68, No. 6
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Overexpression of Protective Antigen as a Novel
Approach To Enhance Vaccine Efficacy of Brucella abortus
Strain RB51
Ramesh
Vemulapalli,*
Yongqun
He,
Silvio
Cravero,
Nammalwar
Sriranganathan,
Stephen M.
Boyle, and
Gerhardt G.
Schurig
Department of Biomedical Sciences and
Pathobiology, Center for Molecular Medicine and Infectious Diseases,
Virginia-Maryland Regional College of Veterinary Medicine, Virginia
Polytechnic Institute and State University, Blacksburg, Virginia 24061
Received 10 December 1999/Returned for modification 10 February
2000/Accepted 20 March 2000
Brucella abortus strain RB51 is an attenuated rough
strain that is currently being used as the official live vaccine for
bovine brucellosis in the United States and several other countries. We
reasoned that overexpression of a protective antigen(s) of B. abortus in strain RB51 should enhance its vaccine efficacy. To
test this hypothesis, we overexpressed Cu/Zn superoxide dismutase (SOD)
protein of B. abortus in strain RB51. This was accomplished by transforming strain RB51 with a broad-host-range plasmid, pBBR1MCS, containing the sodC gene along with its promoter. Strain
RB51 overexpressing SOD (RB51SOD) was tested in BALB/c mice for its ability to protect against challenge infection with virulent strain 2308. Mice vaccinated with RB51SOD, but not RB51, developed antibodies and cell-mediated immune responses to Cu/Zn SOD. Strain RB51SOD vaccinated mice developed significantly (P < 0.05)
more resistance to challenge than those vaccinated with strain RB51
alone. The presence of the plasmid alone in strain RB51 did not alter
its vaccine efficacy. Also, overexpression of SOD did not alter the attenuation characteristic of strain RB51.
*
Corresponding author. Mailing address: Center for
Molecular Medicine and Infectious Diseases, 1410 Prices Fork Rd.,
Blacksburg, VA 24061. Phone: (540) 231-7757. Fax: (540) 231-3426. E-mail: rvemulap{at}vt.edu.
Infection and Immunity, June 2000, p. 3286-3289, Vol. 68, No. 6
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Olsen, S. C., Boyle, S. M., Schurig, G. G., Sriranganathan, N. N.
(2009). Immune Responses and Protection against Experimental Challenge after Vaccination of Bison with Brucella abortus Strain RB51 or RB51 Overexpressing Superoxide Dismutase and Glycosyltransferase Genes. CVI
16: 535-540
[Abstract]
[Full Text]
-
Bhattacharjee, A. K., Izadjoo, M. J., Zollinger, W. D., Nikolich, M. P., Hoover, D. L.
(2006). Comparison of Protective Efficacy of Subcutaneous versus Intranasal Immunization of Mice with a Brucella melitensis Lipopolysaccharide Subunit Vaccine.. Infect. Immun.
74: 5820-5825
[Abstract]
[Full Text]
-
Luo, D., Ni, B., Li, P., Shi, W., Zhang, S., Han, Y., Mao, L., He, Y., Wu, Y., Wang, X.
(2006). Protective Immunity Elicited by a Divalent DNA Vaccine Encoding Both the L7/L12 and Omp16 Genes of Brucella abortus in BALB/c Mice.. Infect. Immun.
74: 2734-2741
[Abstract]
[Full Text]
-
Vemulapalli, T. H., Vemulapalli, R., Schurig, G. G., Boyle, S. M., Sriranganathan, N.
(2006). Role in Virulence of a Brucella abortus Protein Exhibiting Lectin-Like Activity. Infect. Immun.
74: 183-191
[Abstract]
[Full Text]
-
Sanakkayala, N., Sokolovska, A., Gulani, J., HogenEsch, H., Sriranganathan, N., Boyle, S. M., Schurig, G. G., Vemulapalli, R.
(2005). Induction of Antigen-Specific Th1-Type Immune Responses by Gamma-Irradiated Recombinant Brucella abortus RB51. CVI
12: 1429-1436
[Abstract]
[Full Text]
-
Izadjoo, M. J., Bhattacharjee, A. K., Paranavitana, C. M., Hadfield, T. L., Hoover, D. L.
(2004). Oral Vaccination with Brucella melitensis WR201 Protects Mice against Intranasal Challenge with Virulent Brucella melitensis 16M. Infect. Immun.
72: 4031-4039
[Abstract]
[Full Text]
-
Munoz-Montesino, C., Andrews, E., Rivers, R., Gonzalez-Smith, A., Moraga-Cid, G., Folch, H., Cespedes, S., Onate, A. A.
(2004). Intraspleen Delivery of a DNA Vaccine Coding for Superoxide Dismutase (SOD) of Brucella abortus Induces SOD-Specific CD4+ and CD8+ T Cells. Infect. Immun.
72: 2081-2087
[Abstract]
[Full Text]
-
Onate, A. A., Cespedes, S., Cabrera, A., Rivers, R., Gonzalez, A., Munoz, C., Folch, H., Andrews, E.
(2003). A DNA Vaccine Encoding Cu,Zn Superoxide Dismutase of Brucella abortus Induces Protective Immunity in BALB/c Mice. Infect. Immun.
71: 4857-4861
[Abstract]
[Full Text]
-
He, Y., Vemulapalli, R., Schurig, G. G.
(2002). Recombinant Ochrobactrum anthropi Expressing Brucella abortus Cu,Zn Superoxide Dismutase Protects Mice against B. abortus Infection Only after Switching of Immune Responses to Th1 Type. Infect. Immun.
70: 2535-2543
[Abstract]
[Full Text]
-
Ribeiro, L. A., Azevedo, V., Le Loir, Y., Oliveira, S. C., Dieye, Y., Piard, J.-C., Gruss, A., Langella, P.
(2002). Production and Targeting of the Brucella abortus Antigen L7/L12 in Lactococcus lactis: a First Step towards Food-Grade Live Vaccines against Brucellosis. Appl. Environ. Microbiol.
68: 910-916
[Abstract]
[Full Text]
-
He, Y., Vemulapalli, R., Zeytun, A., Schurig, G. G.
(2001). Induction of Specific Cytotoxic Lymphocytes in Mice Vaccinated with Brucella abortus RB51. Infect. Immun.
69: 5502-5508
[Abstract]
[Full Text]
-
Al-Mariri, A., Tibor, A., Mertens, P., De Bolle, X., Michel, P., Godefroid, J., Walravens, K., Letesson, J.-J.
(2001). Protection of BALB/c Mice against Brucella abortus 544 Challenge by Vaccination with Bacterioferritin or P39 Recombinant Proteins with CpG Oligodeoxynucleotides as Adjuvant. Infect. Immun.
69: 4816-4822
[Abstract]
[Full Text]
-
Vemulapalli, R., He, Y., Boyle, S. M., Sriranganathan, N., Schurig, G. G.
(2000). Brucella abortus Strain RB51 as a Vector for Heterologous Protein Expression and Induction of Specific Th1 Type Immune Responses. Infect. Immun.
68: 3290-3296
[Abstract]
[Full Text]